Human Genome Epidemiology Literature Finder
|
Records 1 - 15 (of 15 Records) |
| Query Trace: Myocardial Infarction and CYP3A5[original query] |
|---|
| Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2006 Jun 174 (12): 1715-22. Suh Jung-Won, Koo Bon-Kwon, Zhang Shu-Ying, Park Kyung-Woo, Cho Joo-Youn, Jang In-Jin, Lee Dong-Soon, Sohn Dae-Won, Lee Myoung-Mook, Kim Hyo-S |
| Genetic determinants of response to clopidogrel and cardiovascular events. The New England journal of medicine 2009 Jan 360 (4): 363-75. Simon Tabassome, Verstuyft Céline, Mary-Krause Murielle, Quteineh Lina, Drouet Elodie, Méneveau Nicolas, Steg P Gabriel, Ferrières Jean, Danchin Nicolas, Becquemont Laurent, |
| Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes. Circulation 2009 May 119 (19): 2553-60. Mega Jessica L, Close Sandra L, Wiviott Stephen D, Shen Lei, Hockett Richard D, Brandt John T, Walker Joseph R, Antman Elliott M, Macias William L, Braunwald Eugene, Sabatine Marc |
| Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) study. JACC. Cardiovascular interventions 2010 Jul 3 (7): 731-41. Jeong Young-Hoon, Kim In-Suk, Park Yongwhi, Kang Min-Kyung, Koh Jin-Sin, Hwang Seok-Jae, Kwak Choong Hwan, Hwang Jin-Yo |
| Hepatic metabolism and transporter gene variants enhance response to rosuvastatin in patients with acute myocardial infarction: the GEOSTAT-1 Study. Circulation. Cardiovascular genetics 2010 Jun 3 (3): 276-85. Bailey Kristian M, Romaine Simon P R, Jackson Beryl M, Farrin Amanda J, Efthymiou Maria, Barth Julian H, Copeland Joanne, McCormack Terry, Whitehead Andrew, Flather Marcus D, Samani Nilesh J, Nixon Jane, Hall Alistair S, Balmforth Anthony J, |
| Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome. Journal of the American College of Cardiology 2011 Jun 57 (25): 2474-83. Campo Gianluca, Parrinello Giovanni, Ferraresi Paolo, Lunghi Barbara, Tebaldi Matteo, Miccoli Matteo, Marchesini Jlenia, Bernardi Francesco, Ferrari Roberto, Valgimigli Mar |
| Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study. British journal of clinical pharmacology 2012 Apr 73 (4): 629-40. Kim In-Suk, Jeong Young-Hoon, Park Yongwhi, Yoon Seong-Eun, Kwon Tae Jung, Park Jeong Rang, Hwang Seok-Jae, Koh Eun-Ha, Kwak Choong Hwan, Hwang Jin-Yong, Kim Sunj |
| Amlodipine, clopidogrel and CYP3A5 genetic variability: effects on platelet reactivity and clinical outcomes after percutaneous coronary intervention. Heart (British Cardiac Society) 2012 Sep 98 (18): 1366-72. Park Kyung Woo, Kang Jeehoon, Park Jin Joo, Yang Han-Mo, Lee Hae-Young, Kang Hyun-Jae, Koo Bon-Kwon, Oh Byung-Hee, Park Young-Bae, Kim Hyo-S |
| Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease. JACC. Cardiovascular interventions 2013 Nov 6 (11): 11. Viviani Anselmi C, Briguori C, Roncarati R, Papa L, Visconti G, Focaccio A, De Micco F, Latronico MV, Pagnotta P, Condorelli G |
| Concomitant Use of Proton-Pump Inhibitors and Clopidogrel Increases the Risk of Adverse Outcomes in Patients With Ischemic Stroke Carrying Reduced-Function CYP2C19*2. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2016 Sep . Yi Xingyang, Han Zhao, Zhou Qiang, Cheng Wen, Lin Jing, Wang Ch |
| Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2016 Aug . Yi Xingyang, Zhou Qiang, Wang Chun, Lin Jing, Cheng Wen, Chi Lif |
| Association of Cytochrome P450 Genetic Variants with Clopidogrel Resistance and Outcomes in Acute Ischemic Stroke. Journal of atherosclerosis and thrombosis 2016 Mar . Yi Xingyang, Lin Jing, Wang Yanfen, Zhou Qiang, Wang Chun, Cheng Wen, Chi Lif |
| Evaluation of On-Clopidogrel platelet reactivity overtime, SYNTAX SCORE, genetic polymorphisms and their relationship to one year clinical outcomes in STEMI patients undergoing PCI. Minerva cardioangiologica 2017 7 66 (1): 16-25. Erathi Harsha V, Durgaprasad Rajasekhar, Velam Vanjakshamma, Pvgk Sarma, Rodda Madhavi, C Kapil, Kanavath Sreedhar |
| [Association of CYP2C19 and CYP3A5 gene polymorphisms with myocardial infarction]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2021 Jan 38 (1): 87-91. Qi Lin, Liang Wei, Qiao Hui, Wang Ruimin, Han Jingxian, Xing Xiaofei, Hu Yuw |
| Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study. Frontiers in pharmacology 2022 12 13 1032995. Azzahhafi Jaouad, Bergmeijer Thomas O, van den Broek Wout W A, Chan Pin Yin Dean R P P, Rayhi Senna, Peper Joyce, Bor Willem L, Claassens Daniel M F, van Schaik Ron H N, Ten Berg Jurriën |
- Page last reviewed:Feb 1, 2024
- Content source: